期刊文献+

Effect of arsenic sulfide on tissue factor expression in acute promyelocytic leukemia cell lines

Effect of arsenic sulfide on tissue factor expression in acute promyelocytic leukemi-a cell lines
下载PDF
导出
摘要 Objective: To investigate the effect of arsenic sulfide (tetra-arsenic tetra-sulfide As4S4; diarsenic trisulfide As2S3) on tissue factor (TF) expression and procoagulant activity (PCA) of acute promyelocytic leukemia( APL) cell lines ( NB4 and MR2) and the basic mechanism of their role. Methods: NB4 and MR2 cells were respectively treated with As4S4 , As2S3, As4S4 and Cyclohexamide( CHX). PCA of the cells was detected using one-stage clotting assay. TF antigen was detected by ELISA. TF and PML/RARa fusion gene mRNA by semi-quantitive RT-PCR. The PCA and TF antigen of HL-60 and K562 cells were also examined. Results: The PCA and TF antigen level in NB4 and MR2 cells were significantly higher than that in HL-60 and K562 cells. Both As4S4 and As2S3 can down-regulate the TF antigen , TF mRNA transcription and membrane PCA of NB4 and MR2 cells in vitro in a time-dependent manner. The role of As4S4 was stronger than that of As2S3. Both As4S4 and As2S3 had no effect on PML/RARa fusion gene transcription. CHX treatment completely suppressed the down-regulate effect of As4S4 on the TF mRNA expression. Conclusion: As4S4 and As2S3 may down regulate tissue factor expression and PCA of NB4 and MR2 cells. By down-regulating TF expression, As4S4 and As2S3 might be used to improve the DIC-related hemorrhage in APL patients. Elevated TF antigen level of NB4 and MR2 cells may be related to the fusion gene PML/RARa. The modulation of the TF mRNA expression in NB4 and MR2 cells by As4S4 and As2S3 might be indirect and might not involve PML/RARa fusion gene. Objective: To investigate the effect of arsenic sulfide (tetra-arsenic tetra-sulfide As4S4; diarsenic trisulfide As2S3) on tissue factor (TF) expression and procoagulant activity (PCA) of acute promyelocytic leukemia(APL) cell lines (NB4 and MR2) and the basic mechanism of their role. Methods: NB4 and MR2 cells were respectively treated with As4S4, As2S3, As4S4 and Cyclohexamide(CHX). PCA of the cells was detected using one-stage clotting assay. TF antigen was detected by ELISA. TF and PML/RARα fusion gene mRNA by semi-quantitive RT-PCR. The PCA and TF antigen of HL-60 and K562 cells were also examined. Results: The PCA and TF antigen level in NB4 and MR2 cells were significantly higher than that in HL-60 and K562 cells. Both As4S4 and As2S3 can down-regulate the TF antigen, TF mRNA transcription and membrane PCA of NB4 and MR2 cells in vitro in a time-dependent manner. The role of As4S4 was stronger than that of As2S3. Both As4S4 and As2S3 had no effect on PML/RARαfusion gene transcription. CHX treatment completely suppressed the down-regulate effect of As4S4 on the TF mRNA expression. Conclusion: As4S4 and As2S3 may down regulate tissue factor expression and PCA of NB4 and MR2 cells. By down-regulating TF expression, As4S4 and As2S3 might be used to improve the DIC-related hemorrhage in APL patients. Elevated TF antigen level of NB4 and MR2 cells may be related to the fusion gene PML/RARα. The modulation of the TF mRNA expression in NB4 and MR2 cells by As4S4 and As2S3 might be indirect and might not involve PML/RARα fusion gene.
出处 《Journal of Medical Colleges of PLA(China)》 CAS 2003年第3期154-158,共5页 中国人民解放军军医大学学报(英文版)
基金 Supported by Chinese Medicine Foundation of Shaanxi Province(No.1999002)
关键词 tetra-arsenic tetra-sulfide (As4S4) diarsenic trisulfide (As2S3) tissue factor acute promyelocytic leukemia 硫化坤 急性前髓细胞性白血病 凝血功能 细胞因子
  • 相关文献

参考文献12

  • 1[1]Warrell RP, de The H, Wang ZY et al. Acute promyelocytic leukemia [J]. N Engl J Med, 1993; 329: 177.
  • 2[2]Kaplan R, Dela Cadena RA. Mechanism of the coagulopathy associated with acute promyelocytic leukemia-clinical conference [J]. Am J Hematol, 1998; 59: 234.
  • 3[3]Falanga A, Barbui T. Coagulopathy of acute promyelocytic leukemia [J]. Acta Hematol, 2001; 106(1-2): 43.
  • 4[4]Lu DP, Qiu JY, Jing B et al. Tetra-arsenic tetra-sulfide for the treatment of acute promyelocytic leukemia: A pilot report [J]. Blood, 2002; 99(9): 3163.
  • 5[5]Barbui T, Finazzi G, Falanga A. The impact of all-trans-retinoic acid on the coagulopathy of acute promyelocytic leukemia [J]. Blood, 1998; 91(9): 3093.
  • 6[6]Falanga A, Lacoviello L, Evangelista V et al. Loss of blasts cell procoagulant activity and improvement of haemostatic variables in patients with acute promyelocytic leukemia administered all-trans-retinoic acid [J]. Blood, 1995; 86(3): 1072.
  • 7[7]Takana M, yamanishi H. The expression of tissue factor antigen and activity on the surface of leukemic cells [J]. Leuk Res, 1993; 17(2): 103.
  • 8[8]Tallman MS, Kwaan HC. Reassessing the haemostatic disorder associated with acute promyelocytic leukemia [J]. Blood, 1992; 79(3): 543.
  • 9[9]De Stefano V, Teofili L, Sica S et al. Effects of all-trans-retinoic acid on procoagulant and fibrinolysis activities of cultured blast cells from patients with acute promyelocytic leukemia [J]. Blood, 1995; 86(3): 3535.
  • 10[10]Guo WM, Wang HL, Zhao WL et al. Effects of all-trans-retinoic acid and arsenic trioxide on tissue factor expression in acute promyelocytic leukemia cells [J]. Chin Med J, 2000; 114(1): 30.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部